Men's Health Women's Health Senior's Health Antioxidants Sports Nutrition Diet & Weight Loss Vitamins & Minerals Herbs Specialty Supplements Targeted Supplements Spa Products Anti-Aging Basics Body Systems Body Structure Book Store Pet Health My Recommendation My Favorite Articles Our Most Popular Specials Bargain Basement Brands

MSM

Health News Archive 229 - Inflammation
<<back to structure/function index

Astaxanthin Promotes Significant Reduction in Systemic Inflammation

C-Reactive Protein levels cut over 20% in subjects taking Astaxanthin.

Cyanotech Corporation, a world leader in producing high-value nutrition and health products from microalgae, has completed a preliminary study of the effects of BioAstin Natural Astaxanthin in humans in reducing systemic inflammation as measured by levels of C-Reactive Protein (CRP) in blood serum.

The double-blind study by an independent research group of 15 subjects taking astaxanthin and eight subjects taking placebo found that subjects who took astaxanthin for 56 days showed an average decrease in their measured CRP levels of over 20%. Subjects who took placebo showed no such decrease. Analysis of the data showed that there was a statistically significant difference between the two treatment conditions, suggesting that astaxanthin may significantly reduce CRP scores.

“While highly encouraging, this finding was based on a small sample size and, ideally, should be replicated in a larger study,” said Dr. Gerald R. Cysewski, Chairman, President and CEO of Cyanotech. “Considering recent literature on the importance of CRP as an indicator of cardiac health, the finding of such a substantial average reduction in CRP after a regimen of astaxanthin is a promising result that deserves further attention.”

C-Reactive Protein (CRP) is one of the acute phase proteins that increase during systemic inflammation. Testing CRP levels in the blood may be a new way to assess cardiovascular disease risk, according to the American Heart Association.

Other research suggests that systemic or silent inflammation may be implicated in many life threatening diseases, such as cancer, heart disease, stroke, diabetes and Alzheimer’s, among others.

“This study adds to the body of research being developed that supports the anti-inflammatory properties of BioAstin Natural Astaxanthin,” noted Dr. Cysewski. “Previous studies have shown the benefit of using astaxanthin for varied inflammation-related conditions, including rheumatoid arthritis, carpal tunnel syndrome, joint soreness and sunburn, among others.”